Bayer (BAYRY) said it is “pleased the Solicitor General supports U. S. Supreme Court review of the petition for a writ of certiorari in the Durnell case and agrees with the company’s arguments on preemption.” Bayer stated: “The company believes that the backing of the U.S. government will be important to the Court’s consideration of its petition. The split among federal circuit courts in the Roundup personal injury litigation, on the cross-cutting question of whether federal law preempts state claims based on failure-to-warn theories, warrants review and resolution by the country’s top court.” CEO Bill Anderson added: “The support of the U.S. Government is an important step and good news for U.S. farmers, who need regulatory clarity. The stakes could not be higher as the misapplication of federal law jeopardizes the availability of innovative tools for farmers and investments in the broader U.S. economy.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- Bayer starts SUNFLOWER study
- Bayer announces MEDRAD Centargo system secures 510(k) clearance
- Dare Bioscience announces return of rights to Oveprene
- Bayer data could ‘somewhat renew’ optimism for Bristol drug, says Morgan Stanley
- Video: Biogen up after Novo weight-loss drug fails to slow Alzheimer’s progress
